Skip to content
OpenCapital
Get started

Strata Critical Medical, Inc. SRTA Q1 2026 earnings

Reported May 6, 2026 · Before market open

Revenue$67.4MBeat by $3.7M
EPS$0.03Beat by $0.07
Revenue estimate$63.7M
EPS estimate-$0.04

Next report

Aug 4, 2026 (In 6 days)
Revenue estimate$67.2M
EPS estimate-$0.04

Financials

Q1 2026

Income statement

See full
Revenue$67.4M+87.4%
Gross profit$14.1M+100%
Operating income-$3.0M+47.7%
Net income$2.2M+162%
EPS (diluted)$0.03+175%

Balance sheet

See full
Cash & equivalents$59.0M+65.3%
Total debt$4.5M-50.7%
Total equity$285.7M+30.0%
Total assets$327.6M+30.8%

Cash flow

See full
Operating cash flow$3.9M+1,679%
CapEx$5.2M+98.1%
Free cash flow-$1.3M+54.8%

Valuation & ratios

Valuation

as of 07/28/26
See full
Market cap$444.75M+18.9%
Enterprise value$390.23M—
P/E8.5×—
P/S1.8×—

Profitability

See full
Gross margin21.7%+1.3pp
Operating margin-7.8%-2.8pp
FCF margin-22.4%+1,712pp

Returns & leverage

See full
Debt / equity0×0.0×
Current ratio5.9×-1.0×

Segments

By segment

See full
Logistics$47.6M—
Clinical$19.8M—

By product

See full
Other Clinical$9.9M—
Transplant Clinical$9.8M—

Versus estimates

Revenue

Q1 2026$67.4MBeat by $3.7M
Q4 2025$66.8MBeat by $6.4MQ3 2025$49.3MMiss by $11.1MQ2 2025$70.8MMiss by $9.1MQ1 2025$54.3MMiss by $11.5MQ4 2024$54.4MBeat by $3.4M

Diluted EPS

Q1 2026$0.03Beat by $0.07
Q4 2025-$0.06Miss by $0.07Q3 2025-$0.06Miss by $0.04Q2 2025-$0.05Miss by $0.01Q1 2025-$0.04Beat by $0.07Q4 2024-$0.12In line

Ask the moment Strata Critical Medical, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Strata Critical Medical, Inc. report Q1 2026 earnings?
Strata Critical Medical, Inc. (SRTA) reported Q1 2026 earnings on May 6, 2026 before market open.
What were Strata Critical Medical, Inc.'s Q1 2026 revenue and EPS?
Strata Critical Medical, Inc. reported revenue of $67.4M and eps of $0.03 for Q1 2026.
Did Strata Critical Medical, Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $63.7M by $3.7M. EPS beat the consensus estimate of $-0.04 by $0.07.
How did Strata Critical Medical, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 24.1% from $54.3M a year earlier.
Where can I find Strata Critical Medical, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-030898) and the 10-Q periodic report (0001628280-26-031032) directly on SEC EDGAR. The filing index links above go to sec.gov.